Editas Medicine Files 8-K Report
Ticker: EDIT · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1650664
| Field | Detail |
|---|---|
| Company | Editas Medicine, Inc. (EDIT) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: EDIT
TL;DR
Editas Medicine filed an 8-K, standard SEC update.
AI Summary
On June 12, 2025, Editas Medicine, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures, other events, and financial statements and exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates ongoing regulatory compliance and reporting for Editas Medicine, Inc. It signals that the company is providing updates to the SEC as required.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not disclose any new material risks or adverse events.
Key Players & Entities
- Editas Medicine, Inc. (company) — Registrant
- June 12, 2025 (date) — Date of earliest event reported
- 11 Hurley Street Cambridge, Massachusetts 02141 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Editas Medicine, Inc.?
The filing is for Regulation FD disclosure, other events, and financial statements and exhibits, as of June 12, 2025.
What is the exact name of the company filing this report?
The exact name of the registrant is Editas Medicine, Inc.
On what date was the earliest event reported in this filing?
The date of the earliest event reported is June 12, 2025.
Where are Editas Medicine, Inc.'s principal executive offices located?
The principal executive offices are located at 11 Hurley Street, Cambridge, Massachusetts 02141.
What is the Commission File Number for Editas Medicine, Inc.?
The Commission File Number for Editas Medicine, Inc. is 001-37687.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Editas Medicine, Inc. (EDIT).